Activist & passive stakes

Investors crossing the 5% ownership line, from SEC Schedule 13D (activist) and 13G (passive) filings. Newest first.

Showing the last 10 days.Sign up free for 90 days
All filings, new and amended.1–10 of 10
  • PassiveAmendment 1
    Nov 14, 2026
    WHWK · Whitehawk Therapeutics, Inc.
    Coastlands Capital LP
    6.19% · 3,653,440 shSEC
  • PassiveAmendment 1
    Nov 14, 2026
    NERV · Minerva Neurosciences, Inc.
    Coastlands Capital LP
    9.99% · 5,052,055 shSEC
  • PassiveAmendment 1
    Nov 14, 2026
    XLO · Xilio Therapeutics, Inc.
    Coastlands Capital LP
    9.99% · 731,573 shSEC
  • PassiveAmendment 1
    Nov 14, 2026
    ELOX · Eloxx Pharmaceuticals, Inc.
    Coastlands Capital LP
    9.99% · 422,716 shSEC
  • PassiveAmendment 1
    Nov 14, 2026
    XFOR · X4 Pharmaceuticals, Inc.
    Coastlands Capital LP
    9.99% · 10,719,139 shSEC
  • PassiveAmendment 2
    Nov 14, 2026
    CAMP · CAMP4 Therapeutics Corporation
    Coastlands Capital LP
    9.99% · 6,328,175 shSEC
  • PassiveAmendment 1
    Nov 14, 2026
    ANTX · AN2 Therapeutics, Inc.
    Coastlands Capital LP
    9.99% · 3,803,851 shSEC
  • PassiveNew
    Nov 13, 2026
    STLA · Stellantis N.V.
    Morgan Stanley
    6.9% · 203,355,017 shSEC
  • PassiveNew
    Nov 9, 2026
    STRO · Sutro Biopharma, Inc.
    Coastlands Capital LP
    5.14% · 852,669 shSEC
  • PassiveNew
    Nov 6, 2026
    BOLT · Bolt Biotherapeutics, Inc.
    Coastlands Capital LP
    17.5% · 412,416 shSEC